Quest Diagnostics Inc launches the EGFR Pathway test (KRAS with reflex to NRAS, BRAF), the first laboratory-developed test from a national commercial reference laboratory for comprehensively identifying, in a single reflex test offering, genetic mutations in the KRAS, NRAS and BRAF genes.
Read More
PCR dominates the action, but other technologies are up and coming.
Read MoreEnterprise Analysis Corp, a healthcare consulting and market research firm, announces the publication of its latest multi-client market study: Molecular Diagnostics Survey 2009: A Report on the Status of the US Market.
Read MoreThe American Society for Clinical Pathology (ASCP) has joined the American Civil Liberties Union (ACLU) in a suit challenging the legality of patents on human genes specifically, genes associated with with breast and ovarian cancer.
Read MoreTo “get personalized medicine right,” HHS Secretary Sebelius will need to “create and implement a reasonable and responsible regulatory framework” for genetic tests and other advanced medical diagnostics.
Read More